Related Experiment Video
Updated: Sep 28, 2025

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model
Published on: November 6, 2020
Candida meningitis/ventriculitis over a decade. Increased morbidity and length of stay a concern
Louise Kelly1, Jennifer Walsh1, Mairead Skally1
1Department of Clinical Microbiology, Beaumont Hospital, Dublin, Ireland.
Aim:
The primary aim of this study was to review the diagnosis, management and outcome of Candida meningitis/ventriculitis in our hospital over a ten-year period.
Materials And Methods:
We retrospectively reviewed all culture and 18s rRNA nucleic acid positive CSF specimens processed between 1st January 2010 and 31st December 2020. Patient records were subsequently reviewed to assess the significance of the isolate.
Results:
Of 851 culture-positive cerebrospinal fluid (CSF) specimens, Candida spp. were isolated from 29 (3.4%), representing infection in 12 patients. One culture-negative specimen was positive for Candida on 18s rRNA testing. Of the 13 patients, eight were male; 61.5% and the median age was 47 years; range: 20-70. The median interval from admission to onset of infection and culture positivity was 24 days (range: 1-63 days). All patients had a central nervous system (CNS) device in situ (external ventricular drain: 11; ventriculoperitoneal shunt: 1; lumbar drain: 1). Four were colonised with Candida spp. before meningitis/ventriculitis diagnosis, from wounds (n = 3), respiratory (n = 3), and urine (n = 1) specimens. On culture, the most common species was Candida albicans (n = 8), followed by C. parapsilosis (n = 2), C. tropicalis (n = 1), and C. dubliniensis (n = 1). The median number of follow-up CSFs per patient was nine (range; 3-22), with a median of 6 days to CSF sterility (range 3-10 days). Treatment included; liposomal amphotericin B (n = 5), fluconazole (n = 2), liposomal amphotericin B, and flucytosine (n = 2), liposomal amphotericin B, fluconazole and flucytosine (n = 3), and intra-ventricular amphotericin B (n = 1). Median treatment duration was 25 days (range 11-76) and CNS device removal occurred in 12 patients. The median length-of-stay (LOS) was 58 days (range 24-406). On discharge, moderate to severe disability (Modified Rankin Scale [mRS] 3-5) was evident in eight patients. Two patients died and one was lost to follow-up.
Conclusion:
Meningitis/ventriculitis due to Candida spp. is an uncommon but challenging infection, usually associated with a device, increased morbidity, LOS, and necessitating prolonged treatment. Neurosurgeons need to be aware of these issues in managing and in communicating with such complex patients.
Insights
Candida meningitis/ventriculitis is a rare but severe infection, often linked to central nervous system devices. Prompt diagnosis and prolonged treatment are crucial for managing this challenging condition and improving patient outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Neuroscience
Background:
- Candida meningitis/ventriculitis is an uncommon yet serious infection.
- It is frequently associated with the presence of central nervous system (CNS) devices.
- This condition poses significant management challenges and is linked to increased morbidity.
Purpose of the Study:
- To review the diagnosis, management, and outcomes of Candida meningitis/ventriculitis over a 10-year period.
- To assess the clinical significance of Candida isolates in cerebrospinal fluid (CSF).
- To inform neurosurgeons about the complexities of managing these infections.
Main Methods:
- Retrospective review of culture and 18s rRNA nucleic acid positive CSF specimens from 2010-2020.
- Analysis of patient records to evaluate the significance of Candida isolates.
- Assessment of treatment regimens, duration, CNS device management, and patient outcomes.
Main Results:
- 13 patients were identified with Candida meningitis/ventriculitis, often associated with CNS devices (100%).
- Candida albicans was the most common species (8/12), with infections often occurring after hospital admission (median 24 days).
- Treatment involved various antifungal agents, including liposomal amphotericin B, with a median duration of 25 days; 8 patients experienced moderate to severe disability, and 2 died.
Conclusions:
- Candida meningitis/ventriculitis is a challenging infection requiring prolonged treatment, often necessitating CNS device removal.
- The condition is associated with significant morbidity, prolonged hospital stays, and requires awareness from neurosurgeons.
- Effective management strategies are critical for improving outcomes in patients with these complex infections.
Related Concept Videos
Pneumonia III: Complications and Assessment
Fungal Phylum Microsporidia
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

